As of Aug 28
| +0.06 / +2.26%|
The 2 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 6.25, with a high estimate of 7.50 and a low estimate of 5.00. The median estimate represents a +130.63% increase from the last price of 2.71.
The current consensus among 6 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.